Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope
Microbial Pathogenesis · 2024-01 · 186 · 106467
DOI: 10.1016/j.micpath.2023.106467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2024-01. Verfasst von Mukta Kulshrestha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Central University of Rajasthan, Ajmer, 305817, India. Hauptthemen laut MEDLINE: Phage Therapy, Bacterial Infections, Bacteriophages. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 155 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Central University of Rajasthan, Ajmer, 305817, India.
- Department of Biochemistry, Central University of Rajasthan, Ajmer, 305817, India. Electronic address: vishvanath@curaj.ac.in.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Kulshrestha, M., Tiwari, M., & Tiwari, V. (2024). Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope. Microbial Pathogenesis, 186, 106467. https://doi.org/10.1016/j.micpath.2023.106467
Vancouver
Kulshrestha M, Tiwari M, Tiwari V. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope. Microbial Pathogenesis. 2024;186:106467. doi:10.1016/j.micpath.2023.106467
BibTeX
@article{Kulshrestha2024,
author = {Kulshrestha, Mukta and Tiwari, Monalisa and Tiwari, Vishvanath},
title = {Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope},
journal = {Microbial Pathogenesis},
year = {2024},
volume = {186},
pages = {106467},
doi = {10.1016/j.micpath.2023.106467}
}
EUVIMED